Recent Updates
Recently added Catalysts
VANI Neutral Sentiment

Vivani Medical Reports Second Quarter Financial Results and Provides Business Update

Key Takeaway: Vivani Medical has released its financial results for the second quarter of 2023, along with a business update. The report includes key financial metrics and insights into the company's ongoing operations. Further details on the company's performance and future plans are anticipated in subsequent communications.
Price reaction · baseline $1.22 (2023-08-14 close) · hit after-hours · clean, no other VANI news in the window
day 0 close
-10.7%
day 1
-7.4%
day 3 · peak
-16.4%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight

Full Press Release Details

Blog Post
| August 14, 2023
Vivani Medical Reports Second Quarter Financial Results and Provides Business Update
Read More
Previous Article
Next Article
Blog Navigation
Last updated: Aug 14, 2023